Autonomix Medical (AMIX) Cash & Current Investments (2022 - 2026)

Autonomix Medical (AMIX) has reported Cash & Current Investments for 5 consecutive years, with $7.0 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Cash & Current Investments fell 23.34% year-over-year to $7.0 million in Q1 2026; TTM through Mar 2026 was $7.0 million, a 23.34% decrease from a year earlier, with the FY2026 full-year figure at $7.0 million, down 23.34% from the prior year.
• Cash & Current Investments was $7.0 million for Q1 2026 at Autonomix Medical, down from $9.9 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $11.8 million in Q4 2024 and troughed at $865000.0 in Q1 2023.
• A 5-year average of $6.5 million and a median of $7.3 million in 2025 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments jumped 895.14% in 2024 and dropped 23.34% in 2026, its largest moves.
• Over 5 years, Cash & Current Investments stood at $1.2 million in 2022, then increased by 1.5% to $1.2 million in 2023, then jumped by 870.69% to $11.8 million in 2024, then retreated by 15.98% to $9.9 million in 2025, then slipped by 29.49% to $7.0 million in 2026.
• The last three Cash & Current Investments figures came in at $7.0 million (Q1 2026), $9.9 million (Q4 2025), and $7.5 million (Q3 2025), per Business Quant data.